5q14.3 microdeletion syndrome

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

The condition is caused by mutations affecting the MEF2C gene and deletions in the q14.3 region of chromosome 5

Common symptoms

Autistic behaviorbroad foreheaddelayed speech and language developmenthypotoniahigh foreheadseizurehypoplasia of the corpus callosummotor stereotypy

When to suspect

  • Recommendation 1

    Array CGH has been widely used as a promising diagnostic method

How to test

  • Recommendation 1

    Array CGH has been widely used as a promising diagnostic method

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

Primary care

  • Recommendation 1

    Specialist referrals and therapy

Further support

  • Recommendation 1

    No specific physicians specialize in this condition but NORD recommends various rare disease clinics. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 5q14.3 microdeletion syndrome?

Follow to receive regular updates to the latest research development on this disease via email newsletter.